Company: PBH
Filing Date: 2025-05-09
Form Type: 10-K
Source: 0001295947-25-000017
Chunk: 109

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-09
Form: 10-K
Item: Item 8
Chunk 109
---
5$2,136,986 $158,364 $2,295,350 Intangible Assets, net by Reportable Segment:North American OTC Healthcare$2,068,752 $141,234 $2,209,986 International OTC Healthcare68,234 17,130 85,364 Intangible assets, net – March 31, 2025$2,136,986 $158,364 $2,295,350 (a) Amounts relate to our acquisition of Hydralyte intellectual property on October 1, 2024, giving us the rights to the Hydralyte intellectual property in all remaining jurisdictions with the exception of the United States.(b) In connection with our annual impairment test at February 28, 2025, certain indefinite-lived intangible assets were moved to finite-lived to better reflect our long-term projections for these brands.

60

Year Ended March 31, 2024(In thousands)Indefinite-LivedTradenamesFinite-LivedTradenames and Customer RelationshipsTotalsGross Carrying Amounts   Balance – March 31, 2023$2,168,902 $411,118 $2,580,020 Additions (a)393 680 1,073 Effects of foreign currency exchange rates(2,133)(540)(2,673)Balance – March 31, 2024$2,167,162 $411,258 $2,578,420 Accumulated Amortization   Balance – March 31, 2023$— $238,127 $238,127 Additions— 19,784 19,784 Effects of foreign currency exchange rates— (74)(74)Balance – March 31, 2024$— $257,837 $257,837 Intangible assets, net – March 31, 2024$2,167,162 $153,421 $2,320,583 Intangible Assets, net by Reportable Segment:North American OTC Healthcare$2,092,853 $135,932 $2,228,785 International OTC Healthcare74,309 17,489 91,798 Intangible assets, net – March 31, 2024$2,167,162 $153,421 $2,320,583 (a) On January